{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:54:02Z","timestamp":1791132842628,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601705"],"award-info":[{"award-number":["81601705"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.intimp.2020.106530","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T06:38:06Z","timestamp":1587537486000},"page":"106530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["\u03b1-Bisabolol suppresses the inflammatory response and ECM catabolism in advanced glycation end products-treated chondrocytes and attenuates murine osteoarthritis"],"prefix":"10.1016","volume":"84","author":[{"given":"Cong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunren","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haicheng","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoxiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.intimp.2020.106530_b0005","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.joca.2011.08.004","article-title":"g. Osteoarthritis, Prevalence of symptomatic hip and knee osteoarthritis: a two-phase population-based survey","volume":"19","author":"Guillemin","year":"2011","journal-title":"Osteoarthritis Cartilage"},{"issue":"9991","key":"10.1016\/j.intimp.2020.106530_b0010","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","article-title":"Osteoarthritis","volume":"386","author":"Glyn-Jones","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2020.106530_b0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semarthrit.2009.03.006","article-title":"Primary Osteoarthritis No Longer Primary: Three Subsets with Distinct Etiological, Clinical, and Therapeutic Characteristics","volume":"39","author":"Herrero-Beaumont","year":"2009","journal-title":"Semin. Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.intimp.2020.106530_b0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/ar2655","article-title":"Developments in the scientific understanding of osteoarthritis","volume":"11","author":"Abramson","year":"2009","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2020.106530_b0025","first-page":"1207","article-title":"Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis","volume":"50","author":"Jeroen","year":"2014","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.intimp.2020.106530_b0030","first-page":"129","article-title":"Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy","volume":"23","author":"Yamagishi","year":"2003","journal-title":"Int. J. Clin. Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.intimp.2020.106530_b0035","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1002\/art.21199","article-title":"Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritis","volume":"52","author":"Loeser","year":"2014","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.intimp.2020.106530_b0040","article-title":"Advanced Glycation End Products Induce Peroxisome Proliferator-Activated Receptor \u03b3 Down-Regulation-Related Inflammatory Signals in Human Chondrocytes via Toll-Like Receptor-4 and Receptor for Advanced Glycation End Products","volume":"8","author":"Ying","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.intimp.2020.106530_b0045","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejphar.2010.09.025","article-title":"Advanced glycation end products downregulates peroxisome proliferator-activated receptor \u03b3 expression in cultured rabbit chondrocyte through MAPK pathway","volume":"649","author":"Yang","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl 3","key":"10.1016\/j.intimp.2020.106530_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar2260","article-title":"Peroxisome proliferator-activated receptor gamma 1 expression is diminished in human osteoarthritis cartilage and is downregulated by IL-1\u03b2 in articular chondrocytes","volume":"9","author":"Afif","year":"2007","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2020.106530_b0055","first-page":"97","article-title":"Increased expression of receptor for advanced glycation end products by synovial tissue macrophages in rheumatoid arthritis","volume":"54","author":"Katsue","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.intimp.2020.106530_b0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/1529-0131(200201)46:1<114::AID-ART10025>3.0.CO;2-P","article-title":"Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis","volume":"46","author":"Nicole","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.intimp.2020.106530_b0065","doi-asserted-by":"crossref","first-page":"R167","DOI":"10.1186\/ar3127","article-title":"Chondroprotective effects and mechanisms of resveratrol in advanced glycation end products-stimulated chondrocytes","volume":"12","author":"Liu","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"70","key":"10.1016\/j.intimp.2020.106530_b0070","first-page":"70","article-title":"Inflammation in osteoarthritis","volume":"70","author":"Abramson","year":"2004","journal-title":"J. Rheumatol. Suppl."},{"issue":"5","key":"10.1016\/j.intimp.2020.106530_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125776","article-title":"The Role of PPAR\u03b3 in Advanced Glycation End Products-Induced Inflammatory Response in Human Chondrocytes","volume":"10","author":"Ma","year":"2015","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.intimp.2020.106530_b0080","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1096\/fasebj.9.9.7601337","article-title":"The MAPK signaling cascade","volume":"9","author":"Seger","year":"1995","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.intimp.2020.106530_b0085","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jep.2008.06.030","article-title":"South African Salvia species: a review of biological activities and phytochemistry","volume":"119","author":"Kamatou","year":"2008","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106530_b0090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jdermsci.2008.06.005","article-title":"Mechanisms of depigmentation by alpha-bisabolol","volume":"52","author":"Kim","year":"2008","journal-title":"J. Dermatol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2020.106530_b0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/14786410802560690","article-title":"Content and composition of the essential oil of Chamomilla recutita (L.) Rauschert from some European countries","volume":"24","author":"Orav","year":"2010","journal-title":"Nat. Prod. Res."},{"issue":"7","key":"10.1016\/j.intimp.2020.106530_b0100","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/j.biortech.2009.11.021","article-title":"Composition and biological activity of the essential oil from leaves of Plinia cerrocampanensis, a new source of alpha-bisabolol","volume":"101","author":"Vila","year":"2010","journal-title":"Bioresour. Technol."},{"issue":"6","key":"10.1016\/j.intimp.2020.106530_b0105","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1089\/jmf.2008.0290","article-title":"Bisabolol-induced gastroprotection against acute gastric lesions: role of prostaglandins, nitric oxide, and KATP+ channels","volume":"12","author":"Bezerra","year":"2009","journal-title":"J. Med. Food"},{"issue":"10","key":"10.1016\/j.intimp.2020.106530_b0110","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.fct.2011.06.076","article-title":"Inhibitory effects of (-)-alpha-bisabolol on LPS-induced inflammatory response in RAW264.7 macrophages","volume":"49","author":"Kim","year":"2011","journal-title":"Food Chem. Toxicol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106530_b0115","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-2591.2006.01073.x","article-title":"The effect of German chamomile (Marticaria recutita L.) extract and tea tree (Melaleuca alternifolia L.) oil used as irrigants on removal of smear layer: a scanning electron microscopy study","volume":"39","author":"Sadr Lahijani","year":"2006","journal-title":"Int. Endod. J."},{"key":"10.1016\/j.intimp.2020.106530_b0120","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.ejmech.2017.10.017","article-title":"Anti-amyloidogenic and anti-apoptotic effect of alpha-bisabolol against Abeta induced neurotoxicity in PC12 cells","volume":"143","author":"Shanmuganathan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.intimp.2020.106530_b0125","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejphar.2018.09.036","article-title":"(-)-alpha-bisabolol prevents neuronal damage and memory deficits through reduction of proinflammatory markers induced by permanent focal cerebral ischemia in mice","volume":"842","author":"Fernandes","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2020.106530_b0130","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4196\/kjpp.2018.22.4.391","article-title":"Anti-inflammatory and utero-relaxant effect of alpha-bisabolol on the pregnant human uterus","volume":"22","author":"Munoz-Perez","year":"2018","journal-title":"Korean J. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106530_b0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ddr.21418","article-title":"Pharmacological interaction of alpha-bisabolol and diclofenac on nociception, inflammation, and gastric integrity in rats","volume":"79","author":"Ortiz","year":"2018","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.intimp.2020.106530_b0140","doi-asserted-by":"crossref","unstructured":"B. RSS, Q. JSS, A. RKL, N. TS, A. RS, B. AS, P. EWM, D. MC, C. HDM, M. IRA, Evidence for the involvement of TNF-\u03b1 and IL-1\u03b2 in the antinociceptive and anti-inflammatory activity of Stachys lavandulifolia Vahl. (Lamiaceae) essential oil and (-)-\u03b1-bisabolol, its main compound, in mice, 191 (2016) 9\u201318.","DOI":"10.1016\/j.jep.2016.06.022"},{"key":"10.1016\/j.intimp.2020.106530_b0145","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.2147\/IJN.S130798","article-title":"alpha-bisabolol-loaded lipid-core nanocapsules reduce lipopolysaccharide-induced pulmonary inflammation in mice","volume":"12","author":"D'Almeida","year":"2017","journal-title":"Int. J. Nanomed.."},{"issue":"2","key":"10.1016\/j.intimp.2020.106530_b0150","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.canlet.2009.10.015","article-title":"Identification of a small molecule inhibitor of serine 276 phosphorylation of the p65 subunit of NF-\u03baB using in silico molecular docking","volume":"291","author":"Law","year":"2010","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.intimp.2020.106530_b0155","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1016\/j.bmcl.2013.04.029","article-title":"Development of indole\/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): Optimization for JNK potency and physicochemical properties","volume":"23","author":"Gong","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.intimp.2020.106530_b0160","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4062\/biomolther.2013.044","article-title":"Silibinin Inhibits LPS-Induced Macrophage Activation by Blocking p38 MAPK in RAW 264.7 Cells","volume":"21","author":"Cha Kyung","year":"2013","journal-title":"Biomol. Ther. (Seoul)"},{"issue":"9","key":"10.1016\/j.intimp.2020.106530_b0165","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.joca.2007.03.006","article-title":"The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129\/SvEv mouse","volume":"15","author":"Glasson","year":"2007","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"10.1016\/j.intimp.2020.106530_b0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.joca.2005.07.014","article-title":"Osteoarthritis cartilage histopathology: grading and staging","volume":"14","author":"Pritzker","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.intimp.2020.106530_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","author":"Vos","year":"2012","journal-title":"Lancet"},{"issue":"Suppl 3","key":"10.1016\/j.intimp.2020.106530_b0180","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar4173","article-title":"Nonsteroidal anti-inflammatory drugs and their risk: a story still in development","volume":"15","author":"Simon","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2020.106530_b0185","unstructured":"S. Vil\u00e1, Inflammation in osteoarthritis, 36(3) (2017) 123\u2013129."},{"issue":"Pt 2","key":"10.1016\/j.intimp.2020.106530_b0190","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1042\/bj3500381","article-title":"Age-related accumulation of Maillard reaction products in human articular cartilage collagen","volume":"350","author":"Verzijl","year":"2000","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.intimp.2020.106530_b0195","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/1529-0131(199905)42:5<1003::AID-ANR20>3.0.CO;2-K","article-title":"Age-related decrease in proteoglycan synthesis of human articular chondrocytes: the role of nonenzymatic glycation","volume":"42","author":"DeGroot","year":"1999","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.intimp.2020.106530_b0200","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s10495-016-1280-z","article-title":"Pioglitazone inhibits advanced glycation end product-induced matrix metalloproteinases and apoptosis by suppressing the activation of MAPK and NF-\u03baB","volume":"21","author":"Zhang","year":"2016","journal-title":"Apoptosis"},{"key":"10.1016\/j.intimp.2020.106530_b0205","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.biopha.2017.04.054","article-title":"Memantine inhibits degradation of the articular cartilage extracellular matrix induced by advanced glycation end products (AGEs)","volume":"91","author":"Zhao","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.intimp.2020.106530_b0210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11926-003-0081-x","article-title":"Advanced glycation endproducts and osteoarthritis","volume":"5","author":"Saudek","year":"2003","journal-title":"Curr. Rheumatol. Rep."},{"issue":"8","key":"10.1016\/j.intimp.2020.106530_b0215","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/rheumatology\/ker134","article-title":"Advanced glycation end products cause collagen II reduction by activating Janus kinase\/signal transducer and activator of transcription 3 pathway in porcine chondrocytes","volume":"50","author":"Huang","year":"2011","journal-title":"Rheumatol. (Oxford)"},{"issue":"9","key":"10.1016\/j.intimp.2020.106530_b0220","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.joca.2006.04.008","article-title":"NF-\u03baB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis","volume":"14","author":"Roman-Blas","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"issue":"2","key":"10.1016\/j.intimp.2020.106530_b0225","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/jcb.20905","article-title":"Roles of COX-2 and iNOS in the bony repair of the injured growth plate cartilage","volume":"99","author":"Arasapam","year":"2010","journal-title":"J. Cell. Biochem."},{"issue":"7","key":"10.1016\/j.intimp.2020.106530_b0230","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/art.10356","article-title":"Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants","volume":"46","author":"Hardy","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.intimp.2020.106530_b0235","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1385\/MB:31:2:151","article-title":"The ERK cascade: a prototype of MAPK signaling","volume":"31","author":"Rubinfeld","year":"2005","journal-title":"Mol. Biotechnol."},{"issue":"8","key":"10.1016\/j.intimp.2020.106530_b0240","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1039\/C8FO00732B","article-title":"Hydroxysafflor yellow A (HSYA) targets the NF-kappaB and MAPK pathways and ameliorates the development of osteoarthritis","volume":"9","author":"Hu","year":"2018","journal-title":"Food Funct."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920302897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920302897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T19:22:12Z","timestamp":1754508132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920302897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":48,"alternative-id":["S1567576920302897"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106530","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b1-Bisabolol suppresses the inflammatory response and ECM catabolism in advanced glycation end products-treated chondrocytes and attenuates murine osteoarthritis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106530"}}